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Summsry 
The study of tissue-derived Mycobacterium leprae provides insights  to the immunopathology of 
leprosy and helps identify broad molecular features necessary for mycobacterial parasitism.  A 
major membrane protein (MMP-II) of in vivo-derived M. teprae previously recognized (Hunter, 
S.W., B. Rivoire,  V. Mehra, B.R.  Bloom, and P.J. Brennan.  1990. J. Biol.  Chem.  265:14065) 
was purified  from extracts  of the organism  and partial  amino acid sequence obtained.  This 
information allowed recognition, within one of the cosmids that encompass the entire M. leprae 
genome, of a complete gene, bfr, encoding a protein of subunit size 18.2 kD. The amino acid 
sequence deduced from the major membrane protein II (MMP-II)  gene revealed considerable 
homology to several  bacterioferritins. Analysis of the native protein demonstrated the iron content, 
absorption spectrum, and large native molecular mass (380 kD) of several known bacterioferritins. 
The ferroxidase-center residues typical  of ferritins  were conserved in the M.  leprae product. 
Oligonucleotides derived from the amino acid sequence of M.  leprae bacterioferritin  enabled 
amplification  of much of the MMP-II gene and the detection of homologous sequences in 
Mycobacterium  paratuberculosis, Mycobacterium  avium,  Mycobacterium  tuberculosis, Mycobacterium 
intracellulare, and Mycobacterium scrofulaceum. The role of this iron-rich protein in the virulence 
of M.  leprae is discussed. 
"][prosy is a chronic disease of the skin and nerves caused 
by Mycobacterium leprae. Chemotherapy is successful  but 
requires protracted multidrug therapy and the continuing evo- 
lution of new drug regimens. The world-wide prevalence of 
leprosy is now estimated at less than 5 million cases com- 
pared with 10-12 million in the mid-1980s (1). Much of this 
decline is attributed to chemotherapy. Nevertheless, leprosy 
still represents a major public health problem within regions 
of Latin  America, Africa,  and  Asia,  many of them  not 
amenable to the standard drug regimens. Hence, the devel- 
opment of a vaccine that could contribute to the eradication 
of the disease  remains a goal of some leprosy research  programs. 
The molecular definition  of M.  leprae is fundamental to 
an understanding of the physiology and metabolism of the 
bacillus and the immunoregulatory  mechanisms underlying 
the disease  and protection against it. The leprosy  bacillus grows 
intracellularly in cells of the reticuloendothelial  system and 
Schwann cells, and it is so well adapted to this habitat that 
it has evaded axenic cultivation  so far (2). The development 
of the armadillo as a relatively rich source of the bacillus has 
allowed extensive study of the physiology of the organism 
(2) and definition of the chemistry of the highly antigenic 
glycoconjugates and their roles in pathogenesis (3). Screening 
of M. leprae genomic libraries with antibodies has also per- 
mitted the isolation of genes that encode protein antigens, 
many of which are related to components of the highly con- 
served family of stress proteins  (4). 
A landmark in leprosy research that may revolutionize our 
knowledge of the basis of the obligate parasitism ofM. leprae 
is the recently initiated "M. leprae genome project" (5). Present 
achievements from this undertaking include an ordered col- 
lection of overlapping clones encompassing the complete chro- 
mosome of M. leprae in which 72 loci have  been mapped (5) 
and the complete sequence of 27 cosmids representing  ap- 
proximately one third of the genome (6; Smith, D.R., un- 
published data). In an attempt to complement this genetic 
approach, we initiated a program to identify and characterize 
the major proteins expressed in vivo by the leprosy bacillus. 
The dominant proteins  from the different subcellular frac- 
tions ofM. leprae were identified in terms of relative size and 
antibody-binding patterns, and some of these were immedi- 
ately recognized as the previously described stress proteins 
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designated major membrane protein I (MMP-I) 1 and major 
membrane protein II (MMP-II). The present study describes 
the purification,  biochemical characterization and  gene se- 
quence of MMP-II,  pointing to a novel '~380-kD bacterio- 
ferritin (Bfr), an iron-rich protein that probably plays a cru- 
cial role in  the intracellular  existence of M.  leprae. 
Materials  and  Methods 
Purification of MMP-II.  M. leprae was purified from irradiated 
armadillo spleens  and livers by the Draper protocol as described 
previously (8). Frozen bacteria (300 rag, dry weight) were resus- 
pended in 3 ml of PBS containing 10 mM EDTA, 1 mM phenyl- 
methylsulfonyl fluoride,  and 1 mM benzamidine and disrupted by 
intermittent probe sonication (W-385  sonicator; Heat Systems- 
Ultrasonics, Inc., Farmingdale, NY) for four 15-rain  periods on 
ice. The suspension was centrifuged at 27,000g for 30 rain to remove 
unbroken cells and cell walls.  The supernatant was  further cen- 
trifuged at 100,000g for 2 h to remove membranes and polysomes. 
Mycobacterial lipoglycans (lipoarabinomannan, lipomannan, and 
phosphatidylinositol mannosides)  were removed from the resulting 
supernatant by fractionation on DEAE-Sephacd (Pharmacia Biotech, 
Inc., Piscataway, NJ) equilibrated in 20 mM piperazine buffer, pH 
5.7. After washing the column with 160 mM LiC104, proteins 
were duted  with  1 M  salt  and  subjected to gd filtration on a 
Sephacryl S-200 (Pharmacia Biotech, Inc.) column (1  x  120 cm) 
equilibrated with PBS. MMP-II in the eluates was monitored by 
SDS-PAGE.  The fractions containing MMP-II  were combined, 
dialyzed against water and concentrated. Further purification of 
MMP-II was accomplished on a reversed phase HPLC column (model 
C4; 0.46  x  25 cm; VYDAC, Hesperia, CA). Proteins were eluted 
from the column at a flow rate of 1 ml/min using a linear gradient 
from 70%  solvent A  (trifluoroacetic acid/water, 0.1:99.9),  30% 
solvent B (trifluoroacetic acid/water/acetonitrile,  0.1:9.9:90) to 30% 
solvent A/70%  solvent B over 40 rain. The final highly purified 
MMP-II was obtained upon elution with a linear gradient from 
70 to 100%  solvent B in 30 min. 
The multimeric form of MMP-II was obtained by affanity chro- 
matography based on the monoclonal antibody CS-41 (7). CS-41 
was purified from ascites fluid by protein G agarose column chro- 
matography (Schleicher & SchueU, Inc., Keene, NH). A 1-ml affinity 
column was constructed by using the Afl~nica antibody orienta- 
tion kit (Schleicher & Schuell, Inc.) as recommended by the manufac- 
turer. The column was equilibrated with PBS, the soluble fraction 
of the bacteria applied and nonspecifically bound proteins were re- 
moved with 1 M NaC1 after washing the column with PBS. MMP-II 
was eluted with 1 M ammonium hydroxide, pH 11.5. Fractions 
were immediately neutralized with 1 M HC1 and dialyzed against 
10 mM Tris-HC1,  pH 7.5 
Amino Acid Sequence of MMP-II.  The pure protein was reduced 
with B-mercaptoethanol and subsequently alkylated with 4-vinyl- 
pyridine. The sample was desalted on a Vydac C4 reversed-phase 
HPLC column (0.46 by 5 cm) under the conditions described above. 
Fractions were pooled, dried, and treated with each of the following 
enzymes:  endoproteinase  Lys-C  (from  Lysobacter enzymogenes) 
(Boehringer Mannheim Corp., Indianapolis,  IN), trypsin (treated 
with tolylsulfonyl phenylahnyl chloromethyl ketone) (Sigma Chem- 
1Abbreviations used in  this paper: Bfr, bacterioferritin; MMP-I, major 
membrane protein I; MMP-II, major membrane protein II; SSC, sodium 
chloride-sodium citrate. 
ical Co., St. Louis, MO), and endoproteinase Asp-N (from Pseudo. 
monasfragi) (Boehringer Mannheim Corp.). Before use, the trypsin 
was repurified by reversed phase HPLC (9). Digestions were ac- 
complished on samples of 200-300 pmol as described by Lee and 
Shively (10). The enzyme/protein ratios were typically 1:50. Pep- 
tide mapping was performed using a capillary HPLC system as de- 
scribed by Davis and Lee (11), equipped with a 0.5-mm microcolumn 
packed with VYDAC C18 resin. The peptides were eluted at a flow 
rate of 0.02 ml/min using a linear gradient from 100% solvent 
A (trifluoroacetic  acid/water, 0.1:99.9) to 40% solvent A/60% sol- 
vent B (trifluoroacetic acid/water/acetonitrile,  0.1:9.9:90) in 60 min. 
Absorbance at 214 nm was  monitored with a SPD-6A UWVIS 
monitor equipped with a microanalytical flow cell (Shimadzu Corp., 
Tokyo, Japan). Peptides were spotted on polyvinylidene difluoride 
membranes (Millipore Corp., Bedford, MA) and subjected to au- 
tomated Edman degradation on a gas-phase sequencer built at City 
of Hope (12) and equipped with a continuous-flow reactor (13). 
The phenylthiohydantoin amino acid derivatives were indicated by 
on-line reversed-phase  HPLC. Sequences were confirmed by fast 
atom bombardment-mass spectrometry as described  (14). 
PCR Amplification of the MMP-II Gene.  The reaction mixture 
contained the DNA template (10 ng) in 100 #I (final volume) of 
10 mM Tris-HC1 buffer, pH 8.0, containing 50 mM KC1, 2 mM 
MgClz, deoxyribonucleotide triphosphates (250/~M each), oligo- 
nucleotide amplimer (1 mM each) and 2.5 U  of Taq polymerase 
(Boehringer Mannheim Corp.). Before addition to the reaction mix- 
ture, the template was boiled for 5 rain. The reaction was carried 
out in the DNA Thermal Cycler (Perkin-Elmer Corp., Norwalk, 
CT) as follows: cycles 1 to 5, 95~  sec, 37~  min, a ramp 
time of 3 rain between 37~  and 70~  70~  min; cycles 6 to 
34,  95~  sec, 57~  min, 70~  rain; cycle 35, 95~  for 
30 sec, 57~  for 1 min, and 70~  for 10 min. Degenerate oligonu- 
cleotides were derived from the amino acid sequence based on the 
usage codon table of the first of the M. leprae genome cosmid clones 
to be sequenced (6) and were synthesized on a DNA synthesizer 
(model 7500; MilliGen/Biosearch, Burlington, MA). The forward 
primer 5'-ATGCAGGGC(T)GAC(T)CCC(G)GAC(T)GT-3' was 
derived from amino acid I to 7 of the NH2-terminal  sequence. The 
following alternative backward primers were used:  5'-CACATA- 
(G)ATA(G)ATA(G)CCG(C)GGCTT-3',  derived from peptide T-11; 
5'-GTGAAA(G)CCCCAGTTC(T)TCCTGCAT-3', derived from 
peptide T-16 (T-16a); and 5'-CTCG(C)GTGAAA(G,C)CCCCAG- 
TTCTCCTGCAT-3', derived from T-16 (T-16b). Oligonucleotides 
5'-AG(A)G(A)AAG(A)TAC(T)TGA(G)TTA(G)AT-3'  derived from 
amino acid 22 to 27 of the NH2-terminal region, were labeled at 
the 5' end with qr-[32p]ATP (15) and used as an internal probe to 
check the specificity of the PCR products on Southern analysis. 
Hybridization was  conducted at  37~  and washed with  tetra- 
methylammonium chloride at 44~  Chemiluminescent detection 
with Lumi-Phos 530 was achieved with the nonradioactive Genius 
kit  (Boehringer Mannheim  Corp.)  according  to  the protocols 
provided by the manufacturer. 
M. leprae Genome Sequencing and Sequence Analysis.  The con- 
struction of a physical genetic map of the M.  leprae genome has 
been described (5). Multiplex sequencing of cosmid B38 was con- 
ducted as described by Church and Kieffer-Higgins (16) and will 
be described in detail elsewhere. The application of multisequence 
analysis  using  the  program  PILEUP  from  Genetic  Computer 
Grouping (GCG, Wisconsin Package) has been described (17). The 
hydropathy plot of the predicted amino acid sequence  was con- 
structed by the method of Kyte and Doolittle (18). 
Southern  Hybridization.  Genomic DNA  from M.  leprae was 
purified as described (19). Purification of armadillo genomic DNA 
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niques were performed according to Maniatis et al. (15). 3-5/zg 
of purified DNA were digested with restriction enzymes and frac- 
tionated in 0.8%  agarose  gel electrophoresis.  The 0.33-kb PCR 
product was labeled  with digoxigenin by primer extension with 
random hexamers (Boehringer Mannheim Corp.). Hybridization 
was conducted at 42~  for 16 h  in buffer containing five times 
the concentration of standard sodium chloride-sodium  citrate (SSC) 
(1  x  SSC is 0.15  M  NaC1  plus 0.015  M  sodium citrate), 0.1% 
N-lauroylsarcosine,  0.02% SDS, 5% (wt/vol) blocking reagent for 
nucleic acid hybridization (Boehringer Mannheim Corp.), and 50% 
formamide (vol/vol). The blots were washed twice for 5 rain at 
room temperature in 2  x  SSC with 0.1% SDS. Stringent washes 
were performed twice for 15 min at 65~  or 40~  in 0.1  x  SSC 
containing 0.1%  SDS. Chemiluminescent detection with Lumi- 
Phos 530 was conducted following the manufacturer recommen- 
dations (Boehringer Mannheim Corp.). Membranes were exposed 
to XAR-2X-RAY  film  (Eastman Kodak Co.,  Rochester, NY). 
Physical  and Chemical  Assays.  Visible-  and UV-absorption  spectra 
of the purified protein were obtained with a Varian Cary 118-C 
double-beam spectrophotometer (Varian Instrument Business, San 
Fernando,  CA)  in  1-cm  pathlength  microcuvettes.  Absorption 
maxima of the reduced product were obtained after mixing in a 
few crystals of sodium dithionite. The iron content of the purified 
protein was determined by inductively coupled plasma-optical emis- 
sion  spectroscopy on an  atomcomp (model 975;  Thermo Jarrell 
Ash, Franklin, MA). The iron content was related to protein con- 
tent as estimated by amino acid analysis in a Beckmen High Perfor- 
mance Amino Acid Analyzer System (Model 6300; Beckman In- 
struments Inc., FuUerton, CA) after the sample had been hydrolyzed 
with 6 M HC1 for 24 h at 110~  Molecular mass estimation was 
performed by gel filtration on Superose 6 fast performance liquid 
chromatography (FPLC) and Sephacryl S-300 columns (Pharmacia 
Biotech, Inc.). Columns were equilibrated with 10 mM Tris-HC1 
pH 7.5 containing 0.15 M NaC1 and calibrated using four standard 
proteins: aldolase (150 kD), catalase (232 kD), ferritin (440 kD), 
and thyroglobulin (669 kD) (Pharmacia LKB). SDS-PAGE was per- 
Figure  1.  Purification  of MMPolI. Silver-stained  SDS-PAGE  of purified 
protein after elution from C4 reversed-phase  column. Molecular  mass stan- 
dards are indicated on the left side. 
formed on uniform 15%  gels or 4-20%  gradient gels according 
to Laemmli (20) and proteins were stained with silver nitrate or 
Coomassie blue. 
Results 
Amino Acid Sequence of MMP-II.  MMP-II  was  initially 
identified as a major band of 22 kD by SDS-PAGE analysis 
of the membrane fraction of leprosy bacillus (7).  However, 
after disrupting  the cells with prolonged sonic oscillation, 
considerable quantities of MMP-II were present in the soluble 
fraction of the bacteria.  The protein was purified from this 
source by conventional chromatography (Fig. 1). Most of the 
lipoarabinomannan,  lipomannan,  and  phosphatidylinositol 
mannosides were successfully removed by passing the soluble 
fraction through DEAE-Sephacryl. Further fractionation of 
the soluble proteins was achieved by Sephacryl S-200 gel filtra- 
tion chromatography from which MMP-II was eluted close 
Table  1.  Partial Amino  Acid Sequence of MMP-II of M.  leprae 
Digest/peptide  Mass  predicted  Mass  observed  Sequence 
LYS-C: 
K-8 
TRYPSIN: 
3575.9  3475,4 
T-11  1089.4  1089.5 
T-16  1611.8  1611.6 
T-18  1415.7  1415.6 
T-23  2463.8  2463.5 
ASP-N: 
A-12  963.0  962.7 
NH2-terminal: 
NA  NA 
MQGDPDVLRLLNEQLTS(E)LTA(INQYFLHSK 
LKPGIIMCR 
MQENWGFTELAER 
ILLLDGLPNYQR 
LLNEQLTSELTAINQYFLHSK 
DGLPNYQR 
MQGDPDVLRLLNEQLTSE 
Digestion conditions with the three different endoproteinases, Lys-C, trypsin, and Asp-N, are described in the text. References to the procedures 
used for amino acid sequencing and mass determination are provided in the text.  NA, not applicable. 
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raining fractions on a C4 reversed-phase HPLC column pro- 
vided  highly purified protein  (Fig.  1).  From 300 mg (dry 
weight) of M.  leprae, 14 mg of soluble protein were recov- 
ered of which 50 ktg were pure MMP-II. 
Amino acid sequencing of MMP-II involved digestion with 
three different endoproteinases: trypsin, Lys-C, and Asp-N. 
Table  1  shows  the list  of peptides  whose sequences were 
confirmed by mass analysis. In one instance, KS, the sequence 
data were incomplete;  however, the correct assignment was 
achieved by overlapping the sequence with T23 and from the 
mass data. The NH2-terminal  sequence as obtained on this 
occasion was different in position 2 from that reported previ- 
ously (7) and is now in accord with the gene sequence (see 
below). 
Amplification of  the MMP-II Gene by PCR.  Oligonucleo- 
tides with low degeneracy were derived from the amino acid 
sequence and three alternative reactions were run. The PCR 
products were analyzed by electrophoresis on agarose gel (Fig. 
2 A),  yielding  multiple  products  in reactions  1 and 2.  A 
Southern  blot  of the  same gel  hybridized  with  the  32p_ 
labeled internal probe showed a single band in each lane (Fig. 
2 B). The measured sizes in base pairs of the hybridizing frag- 
ments were 330 bp for reaction 1, which accounts for 67% 
of the complete gene, and 100 bp for reactions 2 and 3. The 
product  of PCR reaction  1 was employed  for purposes of 
cloning  the 330 bp fragment  in  the pCR II  TM  vector  (In- 
vitrogen,  San Diego,  CA).  The fragment  was  purified by 
agarose gel electrophoresis, labeled with digoxigenin, and em- 
ployed  as a probe in subsequent  experiments. 
Nucleotide Sequence of the MMP-II Gene.  As part of the 
M. leprae genome project being carried out at the Pasteur In- 
stitute and Collaborative Research, Inc. (6), a sequence was 
identified with homology to several Bfr genes. The predicted 
product  of this gene turned out to be identical to that of 
MMP-II and therefore was presumed to originate from the 
same gene; the sequence of the M.  leprae Bfr gene and sur- 
rounding regions are given in Fig. 3. The Bfr gene is located 
within cosmid B38 at positions  15,000-16,549  (the sequence 
data are  available from  Genbank under  accession number 
1  TTGAGTCCACTTCACCGACCG  C  CACGCAATTTGACATATTGTTTACCTCGTCC,  GGTrAAG 
61  TCAGGCTTCACAGTC~GACGCGGCGATGATGGCCCGCAATGTGCCTCC,  GCAGCCT 
121  CCGCAGTCACTCC  C  CCCTCCGCAAGCCCCTCCTATCTCCTTGGACCTCCTCGCAC  CACCT 
181  GCGACCACATCGCACACACTTTCCTTCCTGCCACCGCCACACACACACACCTACATCACC 
241  AAACTT  CCCCACCGCAGGTGACATGCCTCACTACATCCG  CCCTCATGGTATCTCCCTTCA 
301  TTACAAACCCACCCCATGC  CGTCGGG  CAAACAGCTCCCATATrACTCCACTCTAAC  CTAA 
361  CTACCC  CTAAGTAC~TtTFfAGTC  CACTCTCCTCTAAAATTTAACCTACTGACCTGCGAT 
421  TCATATGGTCC  CTTCCACCTCATCCCCCGACACTGCACTAAAATCCCACACTCACCC  GTA 
481  CCTGCTGTACTACATCTGACCCACC  CCCGCCTATACTCTATTCTTACCATAGTCTATTGT 
AAAA~ 
541  TATTTCTGACCATAAACTAAACC  CCAGCTCTC  CTTCCGT  CCAC6q'rTAGCGGTTCCACAT 
§  ++4-~  4 
601  CATCTCI"rAC CCACCTTATAC,  GAGTCTTCATC  CAACCTCATCCGCATGTCTTG  CCCITCC 
M  Q  G  D  P  D  V  L  R  L  L 
661  TTAAC  CAG  CAACTCAC  CAGTCAGCTCACC  C  CTATCAAC  CAGTATTTC  CTCCATTCAAAGA 
N  E  Q  L  T  S  E  L  T  A  I  N  O  Y  F  L  H  S  KK  M- 
1(-8 
721  TGCAAGAAAACTCCGGCTTTACCCAGTTAGCAGACCGCACCCGCCTCGAGTCCTTCCACC 
O  E  N  W  G  F  T  E  L  A  E  R  T  R  V  E  S  F  D  E 
T-16 
781  AAATCCCCCAGCCCGAGCCGATTACCGATCCCATCTTGCTTCTGCACGCCI'FCCCCAATT 
M  R  H  a  E  A  I  T  D  R  I  L  L  L  D  C  L  P  N  Y 
841  ACCAC  CGCATAGCCT  CCTTGCG  CGTTGCTCACACG  CTCCCTCAC  CAATTCCAGC  CACACC 
O  R  I  G  S  L  R  V  C  Q  T  L  R  E  Q  F  E  A  D  L 
T-18 
901 TCGCCATCCAATACGACGTCATGACTCCGCT  CAACC  CCCGAATCATCATCTCCCCGGAAA 
A  I  E  Y  E  V  M  S  R  L.  K  P  C  I  I  M  C  R  E  K 
T-11 
961 AGCACCACAGCACCACCGCTCTACTGTTCCACAAAATCGTGGCTGACGAGGAAGAACACA 
Q  D  S  T  S  A  v  L  L  E  K  I  V  A  D  E  E  E  H  I 
1021 TCCACTACTTCCAAACCCAACTACCCCTTATGCCGCAGCTACCGGAGCAGTTGTACTCCG 
D  Y  L  E  T  Q  L  A  L  M  C  Q  L  G  E  E  L  Y  S  A 
1081  CCCAATCCCTCTCCCCCCCGCCGACTTAACCAGCCCGACGCTAACCTCGCTAGTCCACTC 
Q  C  V  S  R  P  P  S  * 
1141  GTAAGTATAACGTACCCGCCACCACCCGACCCCC,  CACCTAGTCCACGCTCACCCACCGTG 
1201  CATC  CTGCGTTCCCTAGCG  CGCTG  CTCCCG  CTG  CC  CTGACGGTCG  TGCTGTTATGTGGTT 
1261 GTCCGACCACTCTGCCTAGCCGCTCTACGACCCCCACTAATTGTGGCTTCCCCCAGCTAG 
1321 GGATGTGACCATTGAACTACCTGTGCTCGCTGCTGCTGGCCTCCATTGTCGACAAGCTCG 
1381 TCCCCCTCCATCACCTACCAC,  CGTCCGCCCGCCTACCGTGAGGTCCAAGCTGCCCTCCAA 
1441 CG  CTTC  GTC  CATCCGGTTATGGT  CCAACGTGCTTCCCACCATCATTCGTTGACTATGGCT 
Figure  2.  Amplification of the MMP-II  gene by PCR.  (A) Agarose 
gel electrophoresis  of the PCR products;  and (B) Southern  blot with an 
internal probe labeled with 32p. The forward primer was derived from the 
first seven amino acids of the protein.  The alternative backward primers 
T-11, T-16a, and T16b were used  in reactions  1,  2,  and 3,  respectively. 
Figure  3.  Nucleotide sequence  of the M. leprae Bfr gene.  The 1.5 kb 
sequence is derived from a 37 kb sequence of cosmid B38  (Smith D. R., 
unpublished  results; the sequences data are available from Genbank under 
accession number L01095).  The amino acid sequence is shown below the 
coding region.  Some of the peptides sequenced are indicated. The nucleo- 
tides below the asterisk symbols are analogous  to an iron box sequence. 
The nucleotides below the plus symbols correspond to the ribosome binding 
site. 
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(GCG Wisconsin Package) revealed strong sequence conser- 
vation with several other Bfrs. The alignments between the 
sequences  from  Azotobacter  vinelandii  (21;  GB/M83692), 
Escherichia coli (22; GB/M27176), M. paratuberculosis (23; Pit/ 
A44893), Nitrobacter winogradskyi  (24; SP/p13570),  and the 
cyanobacterium Synechocystes P.C.C.  6803  (25;  SP/P24602) 
(Fig. 4) shows appreciable homology to the translated M. leprae 
Bfr gene.  Of these,  the M.  leprae sequence is most closely 
related to the partial sequence from M. paratuberculosis. This 
alignment  reveals  a number  of invariant  residues  near  the 
NH2 terminus  of the proteL,..s and  three regions  of strong 
sequence conservation at residues 21-30, 61-70, and 130-138. 
An alignment between M. leprae Bfr and H-like ferritin also 
indicates that the established and putative ferroxidase-center 
residues of ferritins are absolutely conserved or conservatively 
substituted in MMP-II.  These residues are Glu  18,  Tyr 25 
Asp 50, Glu 51, Hist 54, Glu 94, and Glu 127, and, as previ- 
ously shown by Andrews et al. (26) and Grossman et al. (21), 
are conserved in all Bfrs characterized so far (Fig. 4). In addi- 
tion, prediction of MMP-II secondary structure  employing 
the Peptide Structure  Program  (GCG Wisconsin Package) 
indicated a high  (*80%)  c~-helix content,  consistent with 
the presence of the ferritin-like four-helix bundle character- 
istic of other Bfrs (21, 26). The hydropathy plot (not shown) 
of the deduced protein sequence conducted as described (18) 
showed the occurrence of only a few short stretches of hy- 
drophobic amino acids consistent with a soluble/peripheral 
membrane protein. 
At the nucleic acid level, the sequence contains a ribosome 
binding site with significant homology to the 3' end of the 
M. leprae 16S rRNA (27) preceding a methionine start codon 
at nucleotide 630 in Fig. 3. A sequence with significant ho- 
mology to an iron box (28), but without any dyad symmetry, 
occurs in an AT-rich region surrounding nucleotide 540 which 
may correspond to the  transcriptional  initiation  site of the 
gene.  Several regions  of dyad symmetry were noted in the 
sequence, including one centered at nucleotide 177 upstream 
of the gene and at nucleotide 1077 near the translation  ter- 
mination  site. 
Biochemical Characterization  of M.  leprae Bfr.  Crystallo- 
graphic studies (29) and electron microscopic imaging  (23) 
demonstrate that Bfrs share  similar quaternary  structure to 
ferritins.  Ferritins  are multimeric  proteins  that  contain  24 
identical subunits forming a spherical shell enclosing a cen- 
tral cavity that contains up to ~4,500 Fe(III) atoms of non- 
haem iron (30).  However, Bfrs differ from ferritins in that 
they  are  haem  proteins  containing  protoporphyrin  IX  as 
prosthetic group (31-33). To establish whether the M. leprae 
Bfr also shared some of these characteristics,  chemical anal- 
yses were conducted on the native protein.  Small quantities 
of the pure protein were obtained in the native form by affinity 
chromatography based on the monoclonal antibody GS-41. 
i  50 
{A.vibfr}  MKODKIVIQH LNKILGNELI AINQ~  MYEDWGLEKL GKHEYHESID 
{E.cobfr} MKGDTKVINY I.NKI/ENELV AINQYFLHAR MH~qtlGLKRL NDVEYHESID 
{M.lepbfr}  MQCDPDVLRL LI~LTSELT  AINQYFLHSK MQENWGFTEL AERTRVESFD 
~M.paratb}  MQCDPEVLRL I/~EQLTSELT AINQYFLHSK MQDNWGFTEL AE  ........ 
|N.wibfr}  MKODPKVlDu I/qKALRHELT AINQ~/LBYR LLDNWGIKDL AKKWRAESIE 
{Cyanobfr}  14KOKPAVLAQ I/[KI/RGELA ARDQYFIHSR  MYQDWGI2aCL  YSRIDHEMQD 
Consensus  EIKGDP-V---  LNK-L--ELT AINQYFLItSR MY-NWGL-EL AE---HESID 
+  +  + 
51  I00 
{A.vlbfr}  EMKHADKLIK RI~LPN  LQELGKI~IG EHTKEMLECD LKI~ACLPD 
(E.cobfr}  ~{ADRYIE  RILFLEGLPN I~D~IG  EDVEE~B~RSD LALELDGAKN 
{M.lepb~r}  E~tRHAEAITD RI~LPN  YQRIGSLRVG QTLREQFEAD LAIEYEVMSR 
{  H.  paratb  }  .................................................. 
{M.wibfr }  .................................................. 
{  Cyanobfr }  ETHA  .............................................. 
Consensus EM-HAD  .... RILFLEGLPN  -Q--G-L-IG  ....  E-L--D L--E  ...... 
+  +  § 
i01  150 
{A.vibfr}  LKAAIAYCES VGDYASRELL EDILESEEDH IDWLETQLDL IDKIC~ 
{E.eobfr)  LREAIGYADS VHDYVSRDMM IEILRDEECH IDWLErELDL IQKMGLQNYL 
{M.  lepbfr}  IXPGIIMCRE KQDSTSAVLL EKIVADEEEH IDYLETQLAL HGQI~EKLYS 
{  M.  paratb  }  .................................................. 
{  N.wibfr  }  .................................................. 
{  Cyanob  fr  )  .................................................. 
Consensus L---I  .......  D--S--LL  --I---EE-H IDWLET-L-L ....  C---Y- 
§ 
151 
{A.vibfr  ) QSQHDE... 
{E.cobfr  } QAQIREEG. 
{M.  lepbfr}  AQCVSRPPS 
{M.paratb}  ......... 
{N,wibfr  }  ......... 
{  Cyanob  fr  }  ......... 
Consensus  ......... 
Figure 4.  Multisequence  alignment of known Bfr sequences  produced 
with the Genetics Computer Group PILEUP. The amino acids  above  the 
plus symbols  correspond  to the established  and putative  ferroxidase-center 
residues. Program parameters were: plurality: 3.00; threshold: 1.00; av- 
erage weight 0.54; average mismatch -0.40. 
Figure  5.  Coomassie  blue-stained SDS-PAGE  of the multimeric and 
monomeric forms ofM. leprae  Bfr. Lane I, horse spleen ferritin (44 kD); 
lane 2, af~nity-purified  M. leprae  Bfr plus sample  buffer  (not heated); lane 
3, af~nity-purified  M. leprae  Bfr plus sample  buffer (boiled  for 10 min.); 
lane 4, M. leprae  Bfr purified by reversed phase HPLC plus sample  buffer 
(not heated). Molecular mass markers were loaded on the right and left 
lanes of the gel. 
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Fig. 5 shows the presence of multimeric and monomeric forms 
of the Bfr on SDS-PAGE in a 4-20% gradient gel. The affinity 
purified protein,  when  mixed with  sample buffer and  im- 
mediately loaded on the gel,  behaved like a high molecular 
mass  molecule (Fig.  5, lane 2),  close in size to ferritin (440 
kD)  (Fig.  5,  lane I).  By heating  the sample before loading 
on the gel, the multimer dissociated into subunits of approx- 
imate  molecular  mass  20  kD  (Fig.  5,  lane 3).  Fig.  5,  lane 
4  shows  the  subunit  form as  obtained  after reversed-phase 
chromatography (Fig.  1). The molecular mass of the multi- 
Figure  7.  EstimationofthecopynumberoftheBfrgeneintheM.  leprae 
chromosome. Southern blot analysis  ofM./eitrrae DNA digested with BamHl 
(lane a), Eagl (lane b), EcoRI (lane c); EcoRV (lane d), HindlII (lane e), 
KpnI (lane t), Pstl (lane g), SspI (lane h), SmaI (lane 0, Spel (lane  j) and 
Xho (lane k), and hybridized with the digoxigenin-labeled 0.33-kb PCR 
product.  Armadillo  DNA digested with EcoRI was used as a control. 
The numbers on the left show the sizes of the 1-kb ladder (Life Technolo- 
gies, Inc.,  Gaithersburg,  MD). 
meric form of Bfr was estimated by gel filtration to be 380 
kD.  Also,  the  absorption  spectrum  of Bfr  from M.  leprae 
showed a prominent Soret band at 408 nm (Fig. 6), and reduc- 
tion with  sodium  dithionite  shifted the Soret band  to 422 
nm.  The ot and ~  bands  are also detectable with respective 
maxima at 557 and 523 nm. M. leprae Bfr is iron-rich, since, 
on the basis of a molecular mass of 380 kD, it contained of 
the order of 1,000-4,000  atoms of iron per molecule of pro- 
tein as estimated on two different  preparations  of the pure 
protein. 
Figure  8.  Search  for the Bfr gene 
in other mycobacteria. Agarose gel 
electrophoresis  (A)  and Southern 
blot hybridization  patterns  (B) of 
DNA isolated from M. leprae (lane 
1), M.  tuberculosis H37Rv (lane 2), 
M. avium serovar 2 (lane 3), serovar 
4  (lane  4),  serovar  8  (lane 5), 
M. smegmatis  (lane 6),  M.  xenopi 
(lane 7), M. paratuberculosis (lane 8), 
M.  intracellulare  (lane  9),  and 
M. scrofulaceum  (lane  10)  cleaved 
with EcoRI. The DNAs were hy- 
bridized to the digoxigenin-labeled 
0.33-kb  PCK product using  high 
stringent conditions (washes in 0.1 
SSC at 68~  The numbers on the 
left show the sizes of  the 1-kb ladder. 
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mine whether there are multiple homologous copies of the 
Bfr gene in the M. leprae chromosome, genomic DNA from 
M.  leprae was digested with 11 different enzymes followed 
by hybridization with the 330-bp PCR-amplified fragment 
of the gene labeled with digoxigenin. A single band was de- 
tected in each case (Fig.  7). This result, together with the 
information that no tandem copies of the Bfr gene occur in 
the cosmid done, demonstrated that only a single copy of 
the Bfr gene exists in M. leprae. To determine whether other 
mycobacteria possess the Bfr gene or homologous sequences, 
chromosomal DNA from nine different species were digested 
with EcoRI, fragments separated on a gel and hybridized 
with the 330 bp PCR-amplified product of the Bfr gene. 
In high stringency (washes in 0.1  x  SSC at 68~  hybridizing 
bands were detected only in M. leprae and M. paratuberculosis 
(Fig. 8), in agreement with the high homology of the amino 
acid sequence between M. leprae Bfr and antigen D. At strin- 
gent conditions that allowed 20%  of mismatches between 
probe and target DNA (washes in 0.1  x  SSC at 40~  a 
hybridizing band was observed in  the other mycobacteria 
tested, with the exception of M. smegmatis  and M. xenopi. 
Discussion 
Iron is essential to the growth of all living ceils; it is re- 
quired for the transport and storage of oxygen, and as a cata- 
lyst in electron transport processes  (34).  In an aerobic at- 
mosphere, however, iron is extremely insoluble and available 
in limited amounts. Organisms have therefore developed mech- 
anisms for solubilizing iron and, in many cases, for storing 
it  within  particular  molecules.  Animals  have  solved  the 
problem of iron acquisition by using ferritin as a ubiquitous 
iron storage compound and transferrin and lactoferrin for 
movement of iron (35). Little or no free iron then exists within 
animal bodies and pathogenic bacteria must acquire iron from 
such sources. Iron metabolism is therefore considered to play 
a central role in virulence, and a mechanism to scavenge iron 
is a requisite for microbial pathogenicity (36).  In this con- 
text, the observation that one of the most abundant proteins 
present in in vivo grown M. leprae is a Bfr, a protein involved 
in ferrometabolism, must be of considerable significance. 
This present development was due to our technical ability 
to isolate, even from scarce tissue-derived M. leprae, sufficient 
amounts of this major protein to obtain partial amino acid 
sequence, to estimate the size and iron content, and, through 
absorption spectroscopy, establish other relationships to known 
Bfrs.  Oligonucleotides based on the amino acid sequences 
and PCR allowed amplification of a fragment accounting for 
•70%  of the gene. Recognition of the entire gene encoding 
MMP-II was possible  through the new M.  leprae genome 
project. At present, the M. leprae chromosome is represented 
by four "contigs" (or blocks of contiguous DNA sequences) 
or overlapping cosmids, and, by summing their sizes, one 
can estimate the chromosome to have a size of *2.8 mega- 
bases. The sequence of one cosmid has been described in de- 
tail (6), and the sequences of 26 more (18 sequences in Gen- 
bank), or about one third of the M. leprae chromosome, have 
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been determined (Smith, D., unpublished data). Over 300 
M. leprae genes have been identified, and, in many cases, pre- 
cise functions can be attributed on the basis of extensive se- 
quence homology. However, the present work,  in that it 
defines a protein that corresponds to a gene identified in this 
fashion, extends the implications of the research beyond the 
level of comparisons with known gene sequences.  Clearly, 
the derived amino  acid sequence from the MMP-II  gene 
showed significant homology with Bfrs already described in 
the literature (Fig. 4), and it also shared 100% identity with 
the first 42 amino acids  of antigen D, a Bfr isolated from 
M. paratuberculosis (23, 37). Bfrs are haem proteins, and the 
optical spectrum of reduced MMP-II showed o~, 3, and Soret 
bands at 557, 523, and 422 nm, respectively, demonstrating 
the presence of protoporphyrin IX as a prosthetic group. Re- 
cently, a bis-methionine axial ligation of haem has been demon- 
strated in Bfr from Pseudomonas aeroginosa (38),  and, based 
on this information, alternative models involving two con- 
served methionine residues have been postulated as providing 
the haem ligands in other Bfrs (21, 26). With the inclusion 
of the M. leprae Bfr, it can be seen that only the methionine 
at position one remains conserved among the sequences of 
all Bfrs (Fig. 4). These results open up new questions about 
the haem binding site in Bfrs. Fig. 4 also shows that in M. Ieprae 
Bfr, like other Bfrs, the ferroxidase-center residues are con- 
served, which in ferritins are involved in iron oxidation. This 
evidence supports recent indications that Bfrs are distantly 
related to ferritins, constituting a single family of iron pro- 
teins (21,  26). 
The grouping of all ferritins in a single family and their 
phylogenetic distribution in bacteria, fungi, plants, and animals 
implicate ferritin as an obligate protein for aerobic metabo- 
lism. Accordingly, we investigated the conservation of the 
Bfr gene in several mycobacterial species. The presence of se- 
quences homologous to the M.  leprae Bfr gene was clearly 
evident in M. avium, M. tuberculosis, M. paratuberculosis, M. in- 
tracellulare, and M. scrofulaceum, and the absence of hybridizing 
bands in M. smegmatis and M. xenopi at the stringency used 
may merely indicate a  higher divergence between the se- 
quences, since these species are taxonomically more distant 
from M. leprae (39). Among these mycobacteria, the M. para- 
tuberculosis Bfr shared the highest homology with M. leprae 
Bfr (Fig. 8). Interestingly, in terms of iron acquisition, both 
M. leprae and M. paratuberculosis behave similarly. During the 
early stages of growth after isolation from the host, M. para- 
tuberculosis demonstrates  an  obligate  need  for  exogenous 
mycobactins, exochelins or an excess of citric ferric (40). Thus, 
the similarity between the Bfrs ofM. leprae and M. paratuber- 
culosis raises  the possibility that both acquire iron in vivo 
through a similar mechanism in which Bfr plays a central 
role, thereby imposing high conservation on the primary se- 
quences. 
The function of Bfrs is still unclear. Based on their struc- 
tural similarity to ferritins, it has been proposed that Bfrs 
are involved in the safe storage of iron in iron-overloading 
conditions. However, Bfrs differ from their eukaryote analogs 
in two major respects which may be indicative of unique func- 
tions for Bfrs. First, they contain haem residues with proper- ties similar to those of b-type cytochromes.  Indeed, E. coli 
and A.  vinelandii  Bfrs were first isolated as cytochrome bl 
and bss7.s, respectively, and a role for these in electron trans- 
port systems has been proposed (24, 31, 41). The interaction 
between haem components and the ability of Bfrs to store 
nonhaem iron is, however, not understood. Second, in con- 
trast to plants and animals in which ferritin synthesis is in- 
duced by iron (30), the Bfrs subunits retain a constant con- 
centration regardless of the iron status of the cell (25).  Also, 
in iron-deficient cyanobacterium Synechocystes,  Bfrs seem to 
play a role as intermediates  in iron acquisition,  acting as a 
temporary depository (25). However, in overloaded cells, Bfr 
iron represents a very low proportion of the total iron con- 
tent,  and low molecular mass molecules carry the bulk of 
the cellular iron content and fulfill the iron storage function. 
These results are supported by studies performed on E. coli 
in which Bfr iron was shown to represent no more than 1% 
of the total cellular iron,  the bulk of iron in the iron-rich 
cells being in the form of aggregates  (42,  43). 
The mechanism adopted by M.  leprae to acquire iron in- 
side macrophages is unknown.  Macrophages are one of the 
major iron storage cells of the human body, and most iron 
is found as ferritin in the cytosol and as hemosiderin inside 
lysosomal membranes (35). Two major mechanisms by which 
bacteria remove iron from host compounds  have been de- 
scribed. Microbes such as the pathogenic Neisseria spp., possess 
iron acquisition systems using surface receptors for host Fe- 
binding proteins (28). However, in most mycobacteria, iron 
acquisition mechanisms involve two different types of side- 
rophores,  the  extracellular  exochelins  and  the  cell-bound 
mycobactins (44). Also, a set of iron-regulated envelope pro- 
teins  has  been implicated  as exochelins  receptors  (45).  In 
M. leprae, the presence  of exochelins  and mycobactins has 
not yet been demonstrated, but an exochelin-mediated iron 
uptake was demonstrated by using exochelin from either M. ne- 
oaurum or an armadillo derived mycobacterium, ADM 8563. 
Also, iron-regulated envelope proteins have been detected in 
M. leprae, indicating that the leprosy bacillus is growing under 
iron deficiency in the host (2). Might M. leprae Bfr be playing 
the  same function  in  ferrometabolism  as that  observed in 
cyanobacteria?  The  abundance  of Bfr found in  armadillo- 
derived M. leprae, as well as the high iron content of the pro- 
tein,  supports the idea that  Bfr might be functioning  as a 
temporary depository for iron in iron deprivation. Moreover, 
the detection of a potential  iron box around the promoter 
region of the M.  leprae Bfr gene could explain  the overex- 
pression of Bfr in an organism grown under conditions of 
iron deficiency.  The iron box associated with Bfr gene con- 
stitutes the second example of an iron box-like sequence in 
M. leprae, the first one was observed close to a gene encoding 
a putative secreted/cell wall associated protein of 28 kD (46). 
However,  the  relevance  of these sequences in M.  leprae is 
presently unknown. 
The relevance of M.  leprae Bfr as an antigen for purposes 
of diagnosis or vaccine development has not yet been explored. 
In the context of Johne's disease, M. paratuberculosis Bfr is an 
immunodominant B cell antigen, and is the key component 
of a diagnostic test (37). The cloning and overexpression of 
the M. leprae Bfr gene will allow an investigation of the im- 
munological properties of this protein in leprosy. However, 
a clearer definition of the role of Bfr in bacterial ferrometab- 
olism and virulence will be better achieved through isolation 
and characterization  of Bfr mutants  from cultivable patho- 
genic mycobacteria. 
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